2019
DOI: 10.1016/j.ejphar.2019.172490
|View full text |Cite
|
Sign up to set email alerts
|

Astragaloside IV alleviates doxorubicin induced cardiomyopathy by inhibiting NADPH oxidase derived oxidative stress

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
33
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 51 publications
(36 citation statements)
references
References 31 publications
3
33
0
Order By: Relevance
“…Therefore, NOX activation may be considered an important mechanism underlying increased oxidative stress in diabetes [ 32 ]. Studies have shown that NOX2 and NOX4 expression and activity were significantly upregulated under several conditions, including brain ischemia/reperfusion injury [ 33 ], hypertension [ 34 ], hypoxia-related diseases [ 35 ], and DOX-induced cardiomyopathy [ 36 ]. Based on these studies, it is reasonable to speculate that NOX-derived ROS accumulation may be responsible for the impairment of SH-SY5Y cell function when treated with high glucose.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, NOX activation may be considered an important mechanism underlying increased oxidative stress in diabetes [ 32 ]. Studies have shown that NOX2 and NOX4 expression and activity were significantly upregulated under several conditions, including brain ischemia/reperfusion injury [ 33 ], hypertension [ 34 ], hypoxia-related diseases [ 35 ], and DOX-induced cardiomyopathy [ 36 ]. Based on these studies, it is reasonable to speculate that NOX-derived ROS accumulation may be responsible for the impairment of SH-SY5Y cell function when treated with high glucose.…”
Section: Discussionmentioning
confidence: 99%
“…As an exogenous antioxidant, As-IV can significantly protect myocardial cells and mitochondria during the process of heart failure [ 129 131 ]. This protective effect is mainly achieved by an increase in the reserve respiratory capacity of cardiomyocytes and mitochondrial ATP after oxidative stress injury, as well as through the increased activity of T-SOD, GSH-Px, and CAT in cardiomyocytes [ 132 , 133 ]. As-IV can also improve the metabolic rate of cardiomyocytes, reduce the release of MDA and NOS, and inhibit the generation of free oxygen radicals, alleviating damage to the membrane of cardiomyocytes and thus improving their viability [ 134 ].…”
Section: Application Of Antioxidant Natural Drugs For Cardiovasculmentioning
confidence: 99%
“…Among the chemical components, 68% of them were higher in MJ than in MG. Besides, four primary saponins constituents including Astragaloside I, Astragaloside II, Astragaloside III, and especially Astragaloside IV with anti-cancer [28], anti-oxidant [29], anti-inflammatory [30], immune regulation [31], and metabolic regulation activities [32], among others [33,34,35], in MJ were distinctly higher than that in MG. The result offered evidence that MJ may own stronger pharmacological activity and wider application than MG.…”
Section: Resultsmentioning
confidence: 99%